Observational studyScientific reports2022

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC.

Kenichi Koyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.